Search

Your search keyword '"Antiviral agents -- Product introduction"' showing total 41 results
Start Over Descriptor "Antiviral agents -- Product introduction" Topic business
41 results on '"Antiviral agents -- Product introduction"'

1. Germ-O-Guard launches line of innovative new anti-viral and anti-bacterial consumer products

Subjects
Consumer goods -- Product introduction, Antiviral agents -- Product introduction, Antibacterial agents -- Product introduction, Business, News, opinion and commentary
Abstract

Germ-O-Guard anti-viral and anti-bacterial products include face masks, phone, tablet and computer protector skins, handkerchiefs & scarves, adhesive sheets, and rolls of film for custom applications and DiY projects. Using [...]

Published
2022

2. Lactoferrin Market Size to Reach $395.75 million by 2030 - Latest Developments in Nutrition and Health Sector, New Product Launch, Expansion Plans and Future Outlook: The Brainy Insights

Subjects
Infant formulas -- Product introduction, Antiviral agents -- Product introduction, Toiletries industry -- Product introduction, Dietary supplements -- Product introduction, Antifungal agents -- Product introduction, Lactoferrins, Banking, finance and accounting industries, Business
Abstract

Dallas, Feb 02, 2022 (GLOBE NEWSWIRE via COMTEX) -- As per the report published by The Brainy Insights, the global lactoferrin market is expected to grow from USD 142.47 million [...]

Published
2022

3. Fitesa Launches Anti-Viral Product Line

Subjects
Cintas Corp. -- Product introduction -- Officials and employees, Antiviral agents -- Product introduction, Nonwoven fabrics -- Product introduction, Coronaviruses, Business, Fashion, accessories and textiles industries
Abstract

Following a series of investments designed to help in the fight against Covid-19, nonwovens producer Fitesa has expanded its product line to include an antiviral product line with a material [...]

Published
2021

4. 10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19

Subjects
Vaccines -- Product introduction, Antiviral agents -- Product introduction, Autoimmunity, COVID-19, Banking, finance and accounting industries, Business
Abstract

PLEASANTON, Jul 14, 2020 (GLOBE NEWSWIRE via COMTEX) -- 10x Genomics (Nasdaq: TXG) strengthened the research toolkit of scientists around the globe today with the launch of its Chromium Single [...]

Published
2020

5. New Novel Germicidal and Anti-Viral Products from Thin Air Energy(TM)

Subjects
Light-emitting diodes -- Product introduction, Antiviral agents -- Product introduction, Business, News, opinion and commentary
Abstract

TORCH UVc(TM) and GEIGER UVc(TM) Utilize Science-Based Research Proven to Kill Germs and Virus WICHITA, Kan., June 3, 2020 /PRNewswire/ -- Thin Air Energy(TM), a leader in energy storage and [...]

Published
2020

6. AUM LifeTech and AUM BioTech Launch 'Knockdown Coronavirus'

Subjects
Coronavirus infections -- Care and treatment, Biotechnology, Antiviral agents -- Product introduction, Biotechnology industry -- Product introduction, RNA, Coronaviruses, Business, News, opinion and commentary
Abstract

Philadelphia-based Initiative Will Facilitate SARS-CoV-2 Research to Develop Antiviral Therapy for COVID-19 Using RNA Silencing FANA ASO Technology PHILADELPHIA, May 5, 2020 /PRNewswire/ -- The coronavirus pandemic has significantly disrupted [...]

Published
2020

7. Korean Firm HAAN Corporation Launches Breakthrough Antiviral Protection Globally

Subjects
Antiviral agents -- Product introduction, Business, News, opinion and commentary
Abstract

SEOUL, South Korea, April 27, 2020 /PRNewswire/ -- Korean lifestyle product company HAAN Corporation announced that it will launch an unprecedented antiviral formula in South Korea on April 28, along [...]

Published
2020

8. Selected new drugs of 1996

Author

Hussar, Daniel A.

Subjects
Antiviral agents -- Product introduction, Anti-infective agents -- Product introduction, Hypoglycemic agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Health care industry, Retail industry, Product introduction
Abstract

A review of agents that treat HIV, infection, diabetes and ALS In this second part of a two-part series on selected new drugs that have been marketed in 1996, the [...]

Published
1996

9. FDA approves addition of new warnings to hep C drug label

Author

Talsma, Julia

Subjects
Antiviral agents -- Product introduction, Simeprevir -- Product introduction, Business, Pharmaceuticals and cosmetics industries
Abstract

FDA has approved label changes for the hepatitis C antiviral simeprevir (Olysio; Janssen) that will include new warnings about serious symptomatic bradycardia--slowing of the heart rate--when the drug is coadministered [...]

Published
2015

10. NEW DRUGS

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Organon Inc. -- Product introduction -- Laws, regulations and rules, Salix Pharmaceuticals -- Product introduction, Axcan Scandipharm Inc. -- Product introduction, Schering-Plough Corp. -- Product introduction -- Laws, regulations and rules, Enzon Pharmaceuticals Inc. -- Product introduction -- Laws, regulations and rules, Hepatitis -- Laws, regulations and rules, Antiviral agents -- Product introduction, Contraceptives industry -- Product introduction, Pharmaceutical industry -- Product introduction, Oral contraceptives -- Product introduction, Government regulation, Business, Pharmaceuticals and cosmetics industries, Cyclessa (Contraceptive) -- Product introduction, Colazal (Medication) -- Product introduction, Canasa (Medication) -- Product introduction, Peg-Intron (Medication) -- Product introduction
Abstract

Organon Inc., West Orange, N.J., (800) 241-8812, has received FDA approval for Cyclessa (desogestrel/ethinyl estradiol oral contraceptive), the first low-dose (less than 30 mcg of estrogen) triphasic contraceptive. Cyclessa is [...]

Published
2001

11. From antivirals to Viagra: drug review of '98

Subjects
Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Antibacterial agents -- Product introduction, Cardiovascular agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries
Published
1999

12. Companies sock away swine meds; Exelon among firms loading up on anti-virals

Author

Colias, Mike and Saphir, Ann

Subjects
Exelon Corp. -- Product introduction, Antiviral agents -- Product introduction, Swine influenza -- Control, Pharmaceutical industry -- Product introduction, Business, Business, regional
Abstract

Fearing a flu pandemic, some Chicago companies are stockpiling influenza-fighting drugs. Exelon Corp. has stashed thousands of doses of anti-viral medications such as Tamiflu for employees and their dependents in [...]

Published
2009

13. New drugs of 1986

Author

Hussar, Daniel A.

Subjects
Drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Pediculosis -- Care and treatment, Antiviral agents -- Product introduction, Anti-arrhythmia drugs -- Product introduction, New products -- Analysis, Business, Health care industry, Pharmaceuticals and cosmetics industries, Retail industry
Published
1986

14. Marinomed Biotechnologie GmbH's antiviral spray fights cold in Canada

Subjects
Antiviral agents -- Product introduction, Business, Chemicals, plastics and rubber industries
Abstract

An innovative nasal spray that has been proven clinically effective against respiratory viruses has now been authorized for the Canadian market. The product, which was developed by the Viennese biotech [...]

Published
2013

15. South Africa's Aspen unveils anti-AIDS drug

Subjects
Aspen Pharmacare Holdings Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Generic drugs -- Product introduction, Business, Business, general
Published
2003

16. New products in 1994

Author

Hughes, Susan

Subjects
Genentech Inc. -- Product introduction, Roche Holding Ltd. -- Product introduction, Pfizer Inc. -- Product introduction, Upjohn Co. -- Product introduction, Hoechst AG -- Product introduction, Cystic fibrosis -- Drug therapy, Rheumatoid arthritis -- Drug therapy, Subarachnoid hemorrhage -- Drug therapy, Antidepressants -- Product introduction, Alzheimer's disease -- Drug therapy, Antiviral agents -- Product introduction, Immunosuppressive agents -- Product introduction, Antineoplastic agents -- Product introduction, Cardiovascular agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Pulmozyme (Medication) -- Product introduction, Tenidap (Medication) -- Product introduction, Freedox (Medication) -- Product introduction, Velnacrine (Medication) -- Product introduction
Published
1994

17. Reese rollout

Subjects
Reese Pharmaceutical Co. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry, OneTab (Medication) -- Product introduction
Abstract

Reese Pharmaceutical Co. has introduced a line of three O-T-C dye-flee cold- and flu-relief tablet products. Marketed under the brand name OneTab, the individual product offerings are for cold and [...]

Published
2009

18. Roche says that supplies of Tamiflu are adequate

Subjects
Hoffmann-La Roche Inc. -- Product introduction -- Company forecasts, Antiviral agents -- Product introduction, Pharmaceutical industry -- Company forecasts -- Product introduction, Company business forecast/projection, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

Hoffman-La Roche Inc. asserts that its Tamiflu antiviral flu medication will be in ample supply for the 2008/09 flu season. The product, known by its generic name of oseltamivir phosphate, [...]

Published
2008

19. Roche

Subjects
Roche Holding AG -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry, Tamiflu (Medication) -- Product introduction
Abstract

Ample supplies of the flu medication Tamiflu will be available throughout the United States during flu season, manufacturer Roche stated. The Centers for Disease Control and Prevention has cited Tamiflu [...]

Published
2008

20. Abbott urged to provide new version of Kaletra to poor countries

Subjects
Abbott Laboratories (Abbott Park, Illinois) -- Product enhancement, Abbott Laboratories (Abbott Park, Illinois) -- International marketing, Alternative medicine -- International marketing, Antiviral agents -- Product introduction, Antiviral agents -- International marketing, Pharmaceutical industry -- Product introduction, Pharmaceutical industry -- International marketing, Product enhancement, Business, Pharmaceuticals and cosmetics industries
Abstract

A non-governmental organization, Medecins sans Frontieres, has asked Abbott Laboratories to introduce a new version of its antiretroviral drug, Kaletra (lopinavir plus ritonavir) for sale in poor and developing countries.

Published
2006

21. PS debut

Subjects
Antibacterial agents -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

American HomeHealth Inc. has created an 'infection prevention' category with its debut of PS. The brand incorporates a number of antiviral and antibacterial products to help consumers with their cleaning [...]

Published
2006

22. Colorado Serum Co

Subjects
Colorado Serum Co. -- Product introduction, Antiviral agents -- Product introduction, Veterinary drugs -- Product introduction, Pharmaceutical industry -- Product introduction, Agricultural industry, Business, Product introduction
Abstract

Colorado Serum Co., Denver, Colo., introduced its West Nile Virus Antibody-Equine Origin for use as an aid in the control of disease due to West Nile virus in horses. The [...]

Published
2005

23. Banishing bacteria

Author

Cozier, Muriel

Subjects
Perstorp AB -- Product introduction, Anti-infective agents -- Product introduction, Antiviral agents -- Product introduction, Chemical industry -- Product introduction, Herbicides -- Product introduction, Pesticides industry -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries
Abstract

Perstorp has introduced a series of antiviral and anti-microbial moulding compounds. Polygiene can be used to make a number of products including sanitaryware, handles, pens and public phones. The company [...]

Published
2004

24. Geneva Pharmaceuticals

Author

Frederick, James

Subjects
Geneva Pharmaceuticals Inc. -- Product introduction, Hepatitis C -- Care and treatment, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

Last month, Geneva Pharmaceuticals announced that it is moving ahead with its generic production of Schering-Plough's Rebetol (ribavirin), a hepatitis C treatment that generated $721 million in sales for the [...]

Published
2003

25. Gilead Sciences. (UK Drug Update)

Subjects
Gilead Sciences Inc. -- Product introduction, Biological products industry -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries, Hepsera (Medication) -- Product introduction
Published
2003

26. Ranbaxy launches abacavir in India

Subjects
Ranbaxy Laboratories Ltd. -- Product introduction, Ranbaxy Laboratories Ltd. -- Product information, Pharmaceutical industry -- Product information, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Antiviral agents -- Product information, Business, Pharmaceuticals and cosmetics industries
Abstract

Ranbaxy Laboratories' abacavir antiretroviral drug has been launched in India. The drug is marketed under the Virol brand name. It is the generic version of GlaxoSmithKline's Ziagen drug.

Published
2003

27. Roche Products. (UK Drug Update)

Subjects
Roche Products Ltd. -- Product introduction, Influenza -- Drug therapy, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries, Tamiflu (Medication) -- Product introduction
Published
2003

28. 1st launch of B Ingelheim's nevirapine

Subjects
Boehringer Ingelheim GmbH -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Viramune (Medication) -- Product introduction
Published
1996

29. UK launch of oral ganciclovir

Subjects
Roche Holding Ltd. -- Product introduction -- 00401302, Pharmaceutical industry -- Product introduction, Cytomegalovirus infections -- Drug therapy, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Cymevene (Medication) -- Product introduction
Published
1995

30. Gilead's new antivirals

Subjects
Gilead Sciences Inc. -- Product introduction -- 00223651, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries
Published
1995

31. First launches of Wellcome's Valtrex

Subjects
Wellcome PLC -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Shingles (Disease), Business, Pharmaceuticals and cosmetics industries, Valtrex (Medication) -- Product introduction
Published
1995

32. Famvir's launch in the US

Subjects
SmithKline Beecham Corp. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Famvir (Medication) -- Product introduction
Published
1994

33. Ciba launches trifluridine in Italy

Subjects
Italy -- Health aspects, Ciba Vision Corp. -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Triherpine (Medication) -- Product introduction
Published
1994

34. 1st launch for SB's famciclovir - the UK

Subjects
United Kingdom -- Health aspects, SmithKline Beecham Corp. -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Shingles (Disease), Business, Pharmaceuticals and cosmetics industries, Famvir (Medication) -- Product introduction
Published
1994

35. Videx launched in Japan

Subjects
Bristol-Myers Squibb Co. -- Product introduction, Antiviral agents -- Product introduction, Pharmaceutical industry -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Videx (Medication) -- Product introduction
Published
1992

36. Mochida launches vidarabine for herpes in Japan

Subjects
Mochida Pharmaceutical Company Ltd. -- Product introduction, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, Business, Pharmaceuticals and cosmetics industries, Arasena-A (Medication) -- Product introduction
Published
1992

37. Therapeutics

Subjects
Antiviral agents -- Product introduction, Analgesics -- Product introduction, Prostaglandins -- Usage, Business, Business, international, Chemicals, plastics and rubber industries, Engineering and manufacturing industries
Published
1992

38. Agouron girds to join AIDS-drug battle: biotech firm's Viracept is a pricey late entry

Author

Rundle, Rhonda L.

Subjects
Agouron Pharmaceuticals Inc. -- Product introduction -- 00211436, Pharmaceutical industry -- Product introduction, Antiviral agents -- Product introduction, AIDS (Disease) -- Drug therapy, Banking, finance and accounting industries, Business, Business, international, Viracept (Medication) -- Product introduction
Published
1997

39. Schering - pinning its hopes on MS drug

Subjects
Bayer HealthCare Pharmaceuticals -- Product introduction, Antiviral agents -- Product introduction, Multiple sclerosis -- Care and treatment, Business, Business, international, Pharmaceuticals and cosmetics industries
Abstract

Schering expects 20 million US dollar sales in 1993 from Betaseron, a beta interferon targeted at the treatment of relapsing-remitting multiple sclerosis (MS). For 1994, sales of 200 million US dollars are forecast. The product received FDA approval in July 1993, and it hit the US market in October of the same year. The company plans to invest 860 million Deutsche Marks (DM) in 1994 on R&D, compared to DM800 million in 1993.

Published
1993

40. Hepatitis A vaccine - licence potential?

Subjects
Pasteur Merieux Serums et Vaccins S.A. -- Product introduction, Pharmaceutical industry -- Product introduction, Hepatitis A -- Drug therapy, Vaccines -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Pharmaceuticals and cosmetics industries, Avaxim (Medication) -- Product introduction
Abstract

Pharmaceutical joint venture Pasteur Merieux has launched its Avaxin hepatitis A vaccine in the U.K.. The company had been expected to introduce Vaqta, which has received licenses in the U.S. and Germany. Pasteur Merieux's director of business relations says that the two vaccines are very similar.

Published
1996

41. Wellcome launches successor to ageing blockbuster Zovirax

Subjects
Wellcome PLC -- Product introduction, Antiviral agents -- Product introduction, Business, Business, international, Pharmaceuticals and cosmetics industries
Abstract

Wellcome UK has introduced Valtrex, a new antiviral drug and a development of its Zovirax antiviral agent. Valtrex will treat herpes zoster and the company hopes the drug will help it maintain its major share of the antiviral. Valtrex is said to resolve acute shingles pain faster than Zovirax and it has improved bioavailability.

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results